Whether the rare but serious adverse event of erosion with Amplatzer septal-occluder devices should give interventionalists pause before using them is the subject of debate.

Jones explained that there is already one device on the market for transcatheter closure of ASD--the Amplatzer septal occluder (AGA Medical, Plymouth, MN)--which was approved in the US in 2001 and ...

Device achieves 90 percent closure rate for atrial septal defect in children; Biodegradable implant avoids risks associated with metal devices Date: July 15, 2010 Source: Wiley-Blackwell Summary ...

The size of the closure device should be at least 1 mm to 2 mm larger than the ASD measured by echocardiography, as long as sufficient rim is present.

At 2-year follow-up, a septal occluder device was deemed safe and effective for transcatheter closure of atrial septal defects, according to new data published in Circulation: Cardiovascular ...

Global Heart Defect Closure Devices Market 2021-2025 The analyst has been monitoring the heart defect closure devices market and it is poised to grow by $ 3. 31 bn during 2021-2025 progressing at ...

The global heart defect closure devices market research report by Technavio predicts the market to post a CAGR of more than 29% during 2019-2023.

Nickel allergy, increased platelet aggregation, and the presence of microthrombus on the ASD closure device have been proposed as potential mechanisms," Rodés-Cabau's group said.

More information: "A Biodegradable Device (BioSTARTM) for Atrial Septal Defect Closure in Children." Gareth Morgan, Kyong-Jin Lee, Rajiv Chaturvedi, and Lee Benson.